| 4.1 |
8.3 |
GO:0072180 |
mesonephric duct development(GO:0072177) mesonephric duct morphogenesis(GO:0072180) |
| 4.0 |
4.0 |
GO:0061113 |
pancreas morphogenesis(GO:0061113) |
| 3.1 |
12.6 |
GO:0033128 |
negative regulation of histone phosphorylation(GO:0033128) |
| 3.0 |
12.0 |
GO:0072048 |
pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
| 2.9 |
8.8 |
GO:0014028 |
notochord formation(GO:0014028) |
| 2.6 |
7.8 |
GO:0035880 |
embryonic nail plate morphogenesis(GO:0035880) |
| 2.4 |
2.4 |
GO:0033122 |
regulation of purine nucleotide catabolic process(GO:0033121) negative regulation of purine nucleotide catabolic process(GO:0033122) |
| 2.3 |
4.5 |
GO:0060364 |
frontal suture morphogenesis(GO:0060364) |
| 2.2 |
10.8 |
GO:0006447 |
regulation of translational initiation by iron(GO:0006447) positive regulation of translational initiation by iron(GO:0045994) |
| 2.2 |
6.5 |
GO:0070844 |
misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 2.1 |
6.4 |
GO:0060853 |
arterial endothelial cell fate commitment(GO:0060844) blood vessel endothelial cell fate commitment(GO:0060846) endothelial cell fate specification(GO:0060847) Notch signaling pathway involved in arterial endothelial cell fate commitment(GO:0060853) blood vessel endothelial cell fate specification(GO:0097101) |
| 2.1 |
6.2 |
GO:0016332 |
establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
| 2.0 |
2.0 |
GO:0045776 |
negative regulation of blood pressure(GO:0045776) |
| 2.0 |
5.9 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 1.9 |
1.9 |
GO:0030330 |
DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
| 1.9 |
3.8 |
GO:0044413 |
evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
| 1.9 |
17.0 |
GO:0060272 |
embryonic skeletal joint morphogenesis(GO:0060272) |
| 1.8 |
7.3 |
GO:0070858 |
negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 1.8 |
5.4 |
GO:0046370 |
fructose biosynthetic process(GO:0046370) |
| 1.8 |
5.3 |
GO:0086017 |
Purkinje myocyte action potential(GO:0086017) |
| 1.7 |
8.5 |
GO:0046654 |
tetrahydrofolate biosynthetic process(GO:0046654) |
| 1.7 |
5.1 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 1.7 |
5.1 |
GO:0060217 |
hemangioblast cell differentiation(GO:0060217) |
| 1.7 |
1.7 |
GO:0072076 |
nephrogenic mesenchyme development(GO:0072076) |
| 1.7 |
6.6 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 1.6 |
4.9 |
GO:0006106 |
fumarate metabolic process(GO:0006106) |
| 1.6 |
4.9 |
GO:0048296 |
isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
| 1.6 |
1.6 |
GO:0035878 |
nail development(GO:0035878) |
| 1.6 |
1.6 |
GO:0071374 |
cellular response to parathyroid hormone stimulus(GO:0071374) |
| 1.6 |
3.2 |
GO:0006059 |
hexitol metabolic process(GO:0006059) |
| 1.6 |
8.0 |
GO:0010387 |
COP9 signalosome assembly(GO:0010387) |
| 1.5 |
1.5 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 1.5 |
7.7 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 1.5 |
13.5 |
GO:0046499 |
S-adenosylmethioninamine metabolic process(GO:0046499) |
| 1.5 |
4.4 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 1.5 |
4.4 |
GO:0007161 |
calcium-independent cell-matrix adhesion(GO:0007161) |
| 1.5 |
4.4 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 1.5 |
5.8 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 1.4 |
8.7 |
GO:1903755 |
regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 1.4 |
4.3 |
GO:0003162 |
atrioventricular node development(GO:0003162) |
| 1.4 |
1.4 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 1.4 |
1.4 |
GO:0072204 |
cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 1.4 |
2.8 |
GO:0036518 |
chemorepulsion of dopaminergic neuron axon(GO:0036518) |
| 1.4 |
4.1 |
GO:2000832 |
negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
| 1.3 |
4.0 |
GO:0060598 |
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
| 1.3 |
4.0 |
GO:0030421 |
defecation(GO:0030421) |
| 1.3 |
1.3 |
GO:0061642 |
chemoattraction of axon(GO:0061642) |
| 1.3 |
6.5 |
GO:0090135 |
actin filament branching(GO:0090135) |
| 1.3 |
7.7 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 1.3 |
3.8 |
GO:0007521 |
regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) muscle cell fate determination(GO:0007521) |
| 1.2 |
6.0 |
GO:1902570 |
protein localization to nucleolus(GO:1902570) |
| 1.2 |
4.8 |
GO:0001787 |
natural killer cell proliferation(GO:0001787) |
| 1.2 |
4.7 |
GO:0046552 |
eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
| 1.2 |
3.5 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
| 1.2 |
3.5 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
| 1.2 |
1.2 |
GO:2000780 |
negative regulation of double-strand break repair(GO:2000780) |
| 1.2 |
5.8 |
GO:0021905 |
pancreatic A cell development(GO:0003322) forebrain-midbrain boundary formation(GO:0021905) somatic motor neuron fate commitment(GO:0021917) regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment(GO:0021918) positive regulation of cell fate specification(GO:0042660) |
| 1.2 |
3.5 |
GO:0000710 |
meiotic mismatch repair(GO:0000710) |
| 1.2 |
1.2 |
GO:1901420 |
negative regulation of response to alcohol(GO:1901420) |
| 1.1 |
2.3 |
GO:0090309 |
positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 1.1 |
3.4 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 1.1 |
5.6 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 1.1 |
10.0 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 1.1 |
5.6 |
GO:0003420 |
regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
| 1.1 |
1.1 |
GO:0007354 |
zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
| 1.1 |
3.3 |
GO:0042726 |
flavin-containing compound metabolic process(GO:0042726) |
| 1.1 |
1.1 |
GO:0030104 |
water homeostasis(GO:0030104) regulation of water loss via skin(GO:0033561) establishment of skin barrier(GO:0061436) |
| 1.1 |
4.4 |
GO:0006344 |
maintenance of chromatin silencing(GO:0006344) |
| 1.1 |
3.2 |
GO:1900041 |
negative regulation of interleukin-2 secretion(GO:1900041) |
| 1.1 |
3.2 |
GO:0002842 |
T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) positive regulation of T cell mediated immune response to tumor cell(GO:0002842) |
| 1.1 |
4.3 |
GO:0003273 |
cell migration involved in endocardial cushion formation(GO:0003273) |
| 1.1 |
3.2 |
GO:1903011 |
negative regulation of bone development(GO:1903011) |
| 1.1 |
6.4 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
| 1.1 |
4.2 |
GO:0016259 |
selenocysteine metabolic process(GO:0016259) |
| 1.1 |
4.2 |
GO:0046061 |
dATP catabolic process(GO:0046061) |
| 1.0 |
3.1 |
GO:1903334 |
positive regulation of protein folding(GO:1903334) |
| 1.0 |
3.1 |
GO:0009177 |
deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
| 1.0 |
2.1 |
GO:1903998 |
regulation of eating behavior(GO:1903998) |
| 1.0 |
5.1 |
GO:0009954 |
proximal/distal pattern formation(GO:0009954) |
| 1.0 |
3.1 |
GO:1901675 |
response to methylglyoxal(GO:0051595) negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 1.0 |
1.0 |
GO:0061198 |
fungiform papilla formation(GO:0061198) |
| 1.0 |
6.1 |
GO:0016078 |
tRNA catabolic process(GO:0016078) |
| 1.0 |
2.0 |
GO:0021913 |
regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 1.0 |
7.1 |
GO:0061304 |
retinal blood vessel morphogenesis(GO:0061304) |
| 1.0 |
1.0 |
GO:0003016 |
respiratory system process(GO:0003016) |
| 1.0 |
4.1 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 1.0 |
4.0 |
GO:0021986 |
epithalamus development(GO:0021538) habenula development(GO:0021986) general adaptation syndrome(GO:0051866) |
| 1.0 |
2.0 |
GO:0060838 |
lymphatic endothelial cell fate commitment(GO:0060838) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 1.0 |
4.0 |
GO:0071680 |
response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 1.0 |
10.0 |
GO:0021527 |
spinal cord association neuron differentiation(GO:0021527) |
| 1.0 |
1.0 |
GO:0090394 |
negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 1.0 |
9.0 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 1.0 |
2.0 |
GO:1904059 |
regulation of locomotor rhythm(GO:1904059) |
| 1.0 |
7.9 |
GO:0043046 |
DNA methylation involved in gamete generation(GO:0043046) |
| 1.0 |
8.8 |
GO:0002536 |
respiratory burst involved in inflammatory response(GO:0002536) |
| 1.0 |
2.0 |
GO:2001027 |
negative regulation of endothelial cell chemotaxis(GO:2001027) |
| 1.0 |
4.9 |
GO:0040032 |
post-embryonic body morphogenesis(GO:0040032) |
| 1.0 |
2.9 |
GO:0048852 |
diencephalon morphogenesis(GO:0048852) |
| 1.0 |
1.9 |
GO:0010725 |
regulation of primitive erythrocyte differentiation(GO:0010725) |
| 1.0 |
3.9 |
GO:0010510 |
regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
| 1.0 |
2.9 |
GO:0002408 |
myeloid dendritic cell chemotaxis(GO:0002408) |
| 1.0 |
1.0 |
GO:0045976 |
negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
| 1.0 |
4.8 |
GO:0045347 |
negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.9 |
3.8 |
GO:0046294 |
formaldehyde catabolic process(GO:0046294) |
| 0.9 |
3.8 |
GO:1900145 |
regulation of nodal signaling pathway involved in determination of left/right asymmetry(GO:1900145) regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900175) positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) positive regulation of mesoderm development(GO:2000382) |
| 0.9 |
0.9 |
GO:0044828 |
negative regulation by host of viral genome replication(GO:0044828) |
| 0.9 |
3.8 |
GO:0033326 |
cerebrospinal fluid secretion(GO:0033326) |
| 0.9 |
5.7 |
GO:0043137 |
DNA replication, removal of RNA primer(GO:0043137) |
| 0.9 |
2.8 |
GO:0046166 |
glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.9 |
8.5 |
GO:0042487 |
regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 0.9 |
2.8 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.9 |
0.9 |
GO:0033567 |
DNA replication, Okazaki fragment processing(GO:0033567) |
| 0.9 |
0.9 |
GO:0071479 |
cellular response to ionizing radiation(GO:0071479) |
| 0.9 |
0.9 |
GO:0006933 |
negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.9 |
2.8 |
GO:0021557 |
oculomotor nerve development(GO:0021557) |
| 0.9 |
0.9 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 0.9 |
5.5 |
GO:0003383 |
apical constriction(GO:0003383) |
| 0.9 |
4.6 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.9 |
2.7 |
GO:0003360 |
brainstem development(GO:0003360) |
| 0.9 |
4.5 |
GO:2001168 |
regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.9 |
3.6 |
GO:0032463 |
negative regulation of protein homooligomerization(GO:0032463) |
| 0.9 |
9.0 |
GO:0007440 |
foregut morphogenesis(GO:0007440) |
| 0.9 |
0.9 |
GO:1901228 |
positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
| 0.9 |
8.1 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.9 |
5.4 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.9 |
3.5 |
GO:0001705 |
ectoderm formation(GO:0001705) |
| 0.9 |
7.1 |
GO:0085020 |
protein K6-linked ubiquitination(GO:0085020) |
| 0.9 |
4.4 |
GO:0019249 |
lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
| 0.9 |
3.5 |
GO:0060709 |
glycogen cell differentiation involved in embryonic placenta development(GO:0060709) |
| 0.9 |
3.5 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.9 |
0.9 |
GO:0043096 |
purine nucleobase salvage(GO:0043096) |
| 0.9 |
2.6 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.9 |
2.6 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.9 |
1.7 |
GO:0006166 |
purine ribonucleoside salvage(GO:0006166) |
| 0.9 |
1.7 |
GO:1905206 |
positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
| 0.9 |
3.4 |
GO:0007223 |
Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.9 |
1.7 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.8 |
10.1 |
GO:0000059 |
protein import into nucleus, docking(GO:0000059) |
| 0.8 |
2.5 |
GO:2000686 |
regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
| 0.8 |
4.2 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.8 |
5.0 |
GO:0021516 |
dorsal spinal cord development(GO:0021516) |
| 0.8 |
0.8 |
GO:0043550 |
regulation of lipid kinase activity(GO:0043550) |
| 0.8 |
0.8 |
GO:0072205 |
metanephric collecting duct development(GO:0072205) |
| 0.8 |
1.7 |
GO:0046122 |
purine deoxyribonucleoside metabolic process(GO:0046122) |
| 0.8 |
3.3 |
GO:1903898 |
negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
| 0.8 |
2.5 |
GO:0097278 |
complement-dependent cytotoxicity(GO:0097278) |
| 0.8 |
2.5 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 0.8 |
4.1 |
GO:0035087 |
siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 0.8 |
0.8 |
GO:0060743 |
epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.8 |
2.5 |
GO:1902396 |
protein localization to bicellular tight junction(GO:1902396) |
| 0.8 |
3.3 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.8 |
3.2 |
GO:0043973 |
histone H3-K4 acetylation(GO:0043973) |
| 0.8 |
6.4 |
GO:0030174 |
regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.8 |
1.6 |
GO:0070100 |
negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
| 0.8 |
4.8 |
GO:0000733 |
DNA strand renaturation(GO:0000733) |
| 0.8 |
12.7 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.8 |
11.9 |
GO:2000353 |
positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.8 |
3.2 |
GO:0070829 |
heterochromatin maintenance(GO:0070829) |
| 0.8 |
3.9 |
GO:1904667 |
negative regulation of ubiquitin protein ligase activity(GO:1904667) |
| 0.8 |
10.2 |
GO:0042492 |
gamma-delta T cell differentiation(GO:0042492) |
| 0.8 |
5.5 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.8 |
1.6 |
GO:0042990 |
regulation of transcription factor import into nucleus(GO:0042990) transcription factor import into nucleus(GO:0042991) |
| 0.8 |
1.5 |
GO:0045343 |
MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
| 0.8 |
6.2 |
GO:0043922 |
negative regulation by host of viral transcription(GO:0043922) |
| 0.8 |
0.8 |
GO:1901857 |
positive regulation of cellular respiration(GO:1901857) |
| 0.8 |
3.8 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.8 |
2.3 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.8 |
2.3 |
GO:0006271 |
DNA strand elongation involved in DNA replication(GO:0006271) |
| 0.8 |
3.8 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.8 |
3.8 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 0.7 |
1.5 |
GO:0032776 |
DNA methylation on cytosine within a CG sequence(GO:0010424) DNA methylation on cytosine(GO:0032776) |
| 0.7 |
8.2 |
GO:0006000 |
fructose metabolic process(GO:0006000) |
| 0.7 |
3.7 |
GO:0048133 |
germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 0.7 |
4.4 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.7 |
3.0 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.7 |
8.9 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.7 |
2.2 |
GO:0042822 |
vitamin B6 metabolic process(GO:0042816) pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.7 |
6.6 |
GO:0060340 |
positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.7 |
2.2 |
GO:0061626 |
pharyngeal arch artery morphogenesis(GO:0061626) |
| 0.7 |
10.3 |
GO:0006999 |
nuclear pore organization(GO:0006999) |
| 0.7 |
4.4 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.7 |
0.7 |
GO:0042590 |
antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.7 |
2.9 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.7 |
2.2 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.7 |
5.8 |
GO:0050882 |
voluntary musculoskeletal movement(GO:0050882) |
| 0.7 |
3.6 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.7 |
2.1 |
GO:0072675 |
osteoclast fusion(GO:0072675) |
| 0.7 |
2.1 |
GO:0051182 |
coenzyme transport(GO:0051182) |
| 0.7 |
4.9 |
GO:2000491 |
positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.7 |
2.1 |
GO:1904154 |
positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.7 |
2.1 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 0.7 |
0.7 |
GO:0036118 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.7 |
2.0 |
GO:1904690 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.7 |
0.7 |
GO:0033634 |
positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.7 |
2.0 |
GO:0060334 |
regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.7 |
2.0 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.7 |
6.6 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.7 |
4.6 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.7 |
2.0 |
GO:0060982 |
coronary artery morphogenesis(GO:0060982) |
| 0.7 |
2.6 |
GO:1990253 |
cellular response to leucine starvation(GO:1990253) |
| 0.7 |
1.3 |
GO:0090526 |
regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.7 |
7.9 |
GO:0000463 |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.7 |
0.7 |
GO:0035509 |
negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
| 0.7 |
5.2 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.6 |
5.2 |
GO:0038166 |
angiotensin-activated signaling pathway(GO:0038166) |
| 0.6 |
4.5 |
GO:0015675 |
nickel cation transport(GO:0015675) |
| 0.6 |
1.3 |
GO:0060528 |
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.6 |
1.3 |
GO:0010989 |
negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.6 |
0.6 |
GO:0072498 |
embryonic skeletal joint development(GO:0072498) |
| 0.6 |
0.6 |
GO:0046022 |
regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 0.6 |
1.9 |
GO:0015960 |
diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.6 |
2.6 |
GO:0071896 |
protein localization to adherens junction(GO:0071896) |
| 0.6 |
1.9 |
GO:0097623 |
potassium ion export across plasma membrane(GO:0097623) regulation of potassium ion export(GO:1902302) |
| 0.6 |
5.7 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.6 |
1.9 |
GO:0050929 |
corticospinal neuron axon guidance(GO:0021966) corticospinal neuron axon guidance through spinal cord(GO:0021972) positive regulation of negative chemotaxis(GO:0050924) induction of negative chemotaxis(GO:0050929) negative regulation of mononuclear cell migration(GO:0071676) regulation of retinal ganglion cell axon guidance(GO:0090259) negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
| 0.6 |
3.8 |
GO:2000002 |
negative regulation of DNA damage checkpoint(GO:2000002) |
| 0.6 |
1.9 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.6 |
4.4 |
GO:0002523 |
leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.6 |
3.1 |
GO:0015867 |
ATP transport(GO:0015867) |
| 0.6 |
4.4 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.6 |
1.9 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 0.6 |
0.6 |
GO:0070827 |
chromatin maintenance(GO:0070827) |
| 0.6 |
1.8 |
GO:0010814 |
substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.6 |
9.8 |
GO:0060065 |
uterus development(GO:0060065) |
| 0.6 |
3.7 |
GO:0045618 |
positive regulation of keratinocyte differentiation(GO:0045618) |
| 0.6 |
2.4 |
GO:0061188 |
regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.6 |
1.2 |
GO:0031052 |
programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
| 0.6 |
1.2 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.6 |
0.6 |
GO:0032201 |
telomere maintenance via semi-conservative replication(GO:0032201) |
| 0.6 |
3.6 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.6 |
6.7 |
GO:1990173 |
protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
| 0.6 |
1.8 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.6 |
2.4 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.6 |
2.4 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 0.6 |
3.6 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 0.6 |
1.2 |
GO:0032760 |
positive regulation of tumor necrosis factor production(GO:0032760) positive regulation of tumor necrosis factor superfamily cytokine production(GO:1903557) |
| 0.6 |
3.0 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
| 0.6 |
2.4 |
GO:0046909 |
intermembrane transport(GO:0046909) |
| 0.6 |
2.4 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 0.6 |
1.2 |
GO:0000720 |
pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.6 |
1.8 |
GO:0051299 |
centrosome separation(GO:0051299) |
| 0.6 |
0.6 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.6 |
11.2 |
GO:2000052 |
positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.6 |
1.8 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) regulation of opioid receptor signaling pathway(GO:2000474) |
| 0.6 |
0.6 |
GO:0014823 |
response to activity(GO:0014823) |
| 0.6 |
3.5 |
GO:0032796 |
uropod organization(GO:0032796) |
| 0.6 |
1.7 |
GO:0090071 |
negative regulation of ribosome biogenesis(GO:0090071) |
| 0.6 |
4.1 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
| 0.6 |
1.7 |
GO:0014835 |
myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.6 |
1.7 |
GO:0072356 |
chromosome passenger complex localization to kinetochore(GO:0072356) |
| 0.6 |
1.2 |
GO:2000191 |
regulation of fatty acid transport(GO:2000191) |
| 0.6 |
1.2 |
GO:0048853 |
forebrain morphogenesis(GO:0048853) |
| 0.6 |
4.6 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.6 |
7.5 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.6 |
1.7 |
GO:0035907 |
dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
| 0.6 |
1.7 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 0.6 |
14.3 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.6 |
1.1 |
GO:0036509 |
trimming of terminal mannose on B branch(GO:0036509) endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.6 |
1.7 |
GO:0050787 |
glycolate metabolic process(GO:0009441) enzyme active site formation via L-cysteine sulfinic acid(GO:0018323) primary alcohol biosynthetic process(GO:0034309) cellular response to glyoxal(GO:0036471) glycolate biosynthetic process(GO:0046295) detoxification of mercury ion(GO:0050787) positive regulation of superoxide dismutase activity(GO:1901671) negative regulation of TRAIL-activated apoptotic signaling pathway(GO:1903122) regulation of pyrroline-5-carboxylate reductase activity(GO:1903167) positive regulation of pyrroline-5-carboxylate reductase activity(GO:1903168) regulation of tyrosine 3-monooxygenase activity(GO:1903176) positive regulation of tyrosine 3-monooxygenase activity(GO:1903178) L-dopa metabolic process(GO:1903184) L-dopa biosynthetic process(GO:1903185) glyoxal metabolic process(GO:1903189) glyoxal catabolic process(GO:1903190) regulation of L-dopa biosynthetic process(GO:1903195) positive regulation of L-dopa biosynthetic process(GO:1903197) regulation of L-dopa decarboxylase activity(GO:1903198) positive regulation of L-dopa decarboxylase activity(GO:1903200) positive regulation of removal of superoxide radicals(GO:1904833) positive regulation of cellular amino acid biosynthetic process(GO:2000284) positive regulation of androgen receptor activity(GO:2000825) |
| 0.6 |
1.7 |
GO:0003100 |
regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
| 0.6 |
1.7 |
GO:0044778 |
meiotic DNA integrity checkpoint(GO:0044778) |
| 0.6 |
1.7 |
GO:0070535 |
histone H2A K63-linked ubiquitination(GO:0070535) |
| 0.6 |
2.2 |
GO:0097152 |
mesenchymal cell apoptotic process(GO:0097152) |
| 0.6 |
1.7 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 0.6 |
19.4 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.6 |
0.6 |
GO:0070488 |
neutrophil aggregation(GO:0070488) |
| 0.6 |
1.1 |
GO:0003223 |
ventricular compact myocardium morphogenesis(GO:0003223) |
| 0.5 |
1.1 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 0.5 |
2.7 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.5 |
4.9 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.5 |
3.3 |
GO:0003433 |
chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.5 |
6.5 |
GO:0032928 |
regulation of superoxide anion generation(GO:0032928) |
| 0.5 |
10.9 |
GO:0071353 |
cellular response to interleukin-4(GO:0071353) |
| 0.5 |
1.1 |
GO:0046985 |
positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.5 |
1.6 |
GO:0042636 |
negative regulation of hair cycle(GO:0042636) negative regulation of hair follicle development(GO:0051799) |
| 0.5 |
8.7 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.5 |
3.2 |
GO:2000630 |
positive regulation of miRNA metabolic process(GO:2000630) |
| 0.5 |
7.0 |
GO:0071364 |
cellular response to epidermal growth factor stimulus(GO:0071364) |
| 0.5 |
1.6 |
GO:0009446 |
putrescine biosynthetic process(GO:0009446) |
| 0.5 |
1.1 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 0.5 |
0.5 |
GO:0072070 |
distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) loop of Henle development(GO:0072070) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric loop of Henle development(GO:0072236) metanephric DCT cell differentiation(GO:0072240) |
| 0.5 |
3.7 |
GO:0060501 |
positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
| 0.5 |
3.2 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 0.5 |
3.2 |
GO:0035567 |
non-canonical Wnt signaling pathway(GO:0035567) |
| 0.5 |
4.8 |
GO:0090050 |
positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.5 |
2.1 |
GO:1904565 |
response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.5 |
0.5 |
GO:0097167 |
circadian regulation of translation(GO:0097167) |
| 0.5 |
0.5 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.5 |
2.6 |
GO:0018195 |
peptidyl-arginine modification(GO:0018195) |
| 0.5 |
8.9 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.5 |
2.1 |
GO:0030916 |
otic vesicle formation(GO:0030916) |
| 0.5 |
2.6 |
GO:1902775 |
mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.5 |
1.0 |
GO:0042524 |
negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
| 0.5 |
5.7 |
GO:0000183 |
chromatin silencing at rDNA(GO:0000183) |
| 0.5 |
7.3 |
GO:0006346 |
methylation-dependent chromatin silencing(GO:0006346) |
| 0.5 |
4.7 |
GO:0006450 |
regulation of translational fidelity(GO:0006450) |
| 0.5 |
1.0 |
GO:0070093 |
negative regulation of glucagon secretion(GO:0070093) |
| 0.5 |
4.1 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.5 |
3.6 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 0.5 |
3.6 |
GO:0043921 |
modulation by host of viral transcription(GO:0043921) positive regulation by host of viral transcription(GO:0043923) modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) modulation by host of symbiont transcription(GO:0052472) |
| 0.5 |
1.5 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.5 |
1.5 |
GO:0045041 |
protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.5 |
1.0 |
GO:0043586 |
tongue development(GO:0043586) |
| 0.5 |
2.0 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.5 |
2.5 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.5 |
2.5 |
GO:0021775 |
smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
| 0.5 |
0.5 |
GO:0032077 |
positive regulation of deoxyribonuclease activity(GO:0032077) |
| 0.5 |
2.5 |
GO:0060068 |
female genitalia development(GO:0030540) vagina development(GO:0060068) |
| 0.5 |
1.5 |
GO:0042908 |
xenobiotic transport(GO:0042908) |
| 0.5 |
5.5 |
GO:1902459 |
positive regulation of stem cell population maintenance(GO:1902459) |
| 0.5 |
3.0 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
| 0.5 |
4.0 |
GO:0042534 |
tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
| 0.5 |
1.0 |
GO:0000957 |
mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.5 |
2.5 |
GO:1904948 |
midbrain dopaminergic neuron differentiation(GO:1904948) |
| 0.5 |
1.5 |
GO:0090365 |
regulation of mRNA modification(GO:0090365) |
| 0.5 |
0.5 |
GO:0061054 |
dermatome development(GO:0061054) regulation of dermatome development(GO:0061183) |
| 0.5 |
1.5 |
GO:0008608 |
attachment of spindle microtubules to kinetochore(GO:0008608) |
| 0.5 |
1.5 |
GO:0006285 |
base-excision repair, AP site formation(GO:0006285) |
| 0.5 |
1.0 |
GO:0032066 |
nucleolus to nucleoplasm transport(GO:0032066) |
| 0.5 |
2.0 |
GO:0046784 |
viral mRNA export from host cell nucleus(GO:0046784) |
| 0.5 |
0.5 |
GO:0031990 |
mRNA export from nucleus in response to heat stress(GO:0031990) |
| 0.5 |
1.5 |
GO:0031120 |
snRNA pseudouridine synthesis(GO:0031120) |
| 0.5 |
2.9 |
GO:0033631 |
cell-cell adhesion mediated by integrin(GO:0033631) |
| 0.5 |
1.5 |
GO:0030071 |
regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
| 0.5 |
1.5 |
GO:2000653 |
regulation of genetic imprinting(GO:2000653) |
| 0.5 |
1.0 |
GO:0003278 |
apoptotic process involved in heart morphogenesis(GO:0003278) |
| 0.5 |
5.4 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.5 |
1.0 |
GO:0033088 |
negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.5 |
12.2 |
GO:0045880 |
positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.5 |
1.9 |
GO:1990414 |
replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
| 0.5 |
1.0 |
GO:2000628 |
regulation of miRNA metabolic process(GO:2000628) |
| 0.5 |
6.3 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.5 |
2.9 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.5 |
1.9 |
GO:0014846 |
esophagus smooth muscle contraction(GO:0014846) |
| 0.5 |
1.9 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.5 |
1.0 |
GO:1901838 |
positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.5 |
1.4 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.5 |
7.6 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.5 |
1.9 |
GO:1902276 |
pancreatic amylase secretion(GO:0036395) regulation of pancreatic amylase secretion(GO:1902276) |
| 0.5 |
0.5 |
GO:0030422 |
production of siRNA involved in RNA interference(GO:0030422) |
| 0.5 |
1.9 |
GO:0014719 |
skeletal muscle satellite cell activation(GO:0014719) |
| 0.5 |
1.4 |
GO:0010944 |
negative regulation of transcription by competitive promoter binding(GO:0010944) |
| 0.5 |
0.5 |
GO:1901252 |
regulation of intracellular transport of viral material(GO:1901252) |
| 0.5 |
2.8 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.5 |
1.8 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.5 |
8.3 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.5 |
3.2 |
GO:0030903 |
notochord development(GO:0030903) |
| 0.5 |
0.5 |
GO:0000722 |
telomere maintenance via recombination(GO:0000722) |
| 0.5 |
0.9 |
GO:0072202 |
cell differentiation involved in metanephros development(GO:0072202) |
| 0.5 |
1.4 |
GO:0097062 |
dendritic spine maintenance(GO:0097062) |
| 0.5 |
1.4 |
GO:0048698 |
regulation of collateral sprouting in absence of injury(GO:0048696) negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.5 |
1.4 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.5 |
5.9 |
GO:0021978 |
telencephalon regionalization(GO:0021978) |
| 0.4 |
1.8 |
GO:1903237 |
negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.4 |
1.3 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.4 |
2.2 |
GO:0033182 |
regulation of histone ubiquitination(GO:0033182) |
| 0.4 |
2.7 |
GO:0010225 |
response to UV-C(GO:0010225) |
| 0.4 |
0.9 |
GO:0003149 |
membranous septum morphogenesis(GO:0003149) |
| 0.4 |
0.9 |
GO:0002309 |
T cell proliferation involved in immune response(GO:0002309) |
| 0.4 |
5.3 |
GO:0006388 |
tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.4 |
1.8 |
GO:0048702 |
embryonic neurocranium morphogenesis(GO:0048702) |
| 0.4 |
0.9 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.4 |
1.3 |
GO:2000054 |
regulation of chondrocyte development(GO:0061181) regulation of centromeric sister chromatid cohesion(GO:0070602) negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
| 0.4 |
0.9 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
| 0.4 |
0.9 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.4 |
1.7 |
GO:0033209 |
tumor necrosis factor-mediated signaling pathway(GO:0033209) |
| 0.4 |
2.2 |
GO:0032075 |
positive regulation of nuclease activity(GO:0032075) |
| 0.4 |
3.5 |
GO:0038028 |
insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.4 |
2.2 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 0.4 |
1.3 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.4 |
0.4 |
GO:2000170 |
positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 0.4 |
3.0 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 0.4 |
1.3 |
GO:1903204 |
negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.4 |
0.9 |
GO:0030997 |
regulation of centriole-centriole cohesion(GO:0030997) |
| 0.4 |
1.7 |
GO:0035459 |
cargo loading into vesicle(GO:0035459) |
| 0.4 |
1.7 |
GO:0097211 |
response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.4 |
2.6 |
GO:0003065 |
positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.4 |
0.8 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.4 |
0.8 |
GO:0042505 |
tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
| 0.4 |
4.6 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.4 |
0.4 |
GO:0006296 |
nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
| 0.4 |
0.8 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.4 |
1.7 |
GO:0065001 |
negative regulation of histone H3-K36 methylation(GO:0000415) specification of axis polarity(GO:0065001) |
| 0.4 |
13.8 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.4 |
2.9 |
GO:0044872 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.4 |
5.8 |
GO:0042772 |
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) DNA damage response, signal transduction resulting in transcription(GO:0042772) |
| 0.4 |
5.0 |
GO:0021511 |
spinal cord patterning(GO:0021511) |
| 0.4 |
2.5 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.4 |
5.8 |
GO:0009950 |
dorsal/ventral axis specification(GO:0009950) |
| 0.4 |
1.6 |
GO:0015888 |
thiamine transport(GO:0015888) |
| 0.4 |
1.6 |
GO:0060391 |
positive regulation of SMAD protein import into nucleus(GO:0060391) |
| 0.4 |
6.1 |
GO:0010569 |
regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.4 |
0.4 |
GO:0021562 |
vestibulocochlear nerve development(GO:0021562) |
| 0.4 |
3.7 |
GO:1900025 |
negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
| 0.4 |
1.2 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.4 |
10.2 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.4 |
2.8 |
GO:0035563 |
positive regulation of chromatin binding(GO:0035563) |
| 0.4 |
0.8 |
GO:0060261 |
positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 0.4 |
6.4 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.4 |
1.2 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.4 |
1.6 |
GO:2000483 |
negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.4 |
0.4 |
GO:0061298 |
retina vasculature development in camera-type eye(GO:0061298) |
| 0.4 |
2.4 |
GO:0045943 |
positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
| 0.4 |
1.6 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.4 |
2.4 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.4 |
1.6 |
GO:0051315 |
attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 0.4 |
3.9 |
GO:0010388 |
cullin deneddylation(GO:0010388) |
| 0.4 |
0.4 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.4 |
2.4 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
| 0.4 |
0.8 |
GO:1902894 |
negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 0.4 |
6.7 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.4 |
0.4 |
GO:0016188 |
synaptic vesicle maturation(GO:0016188) |
| 0.4 |
2.7 |
GO:0090170 |
regulation of Golgi inheritance(GO:0090170) |
| 0.4 |
1.6 |
GO:0010724 |
regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.4 |
6.6 |
GO:0000303 |
response to superoxide(GO:0000303) |
| 0.4 |
0.4 |
GO:0032627 |
interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
| 0.4 |
1.2 |
GO:0046600 |
negative regulation of centriole replication(GO:0046600) |
| 0.4 |
1.9 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.4 |
1.9 |
GO:0031508 |
pericentric heterochromatin assembly(GO:0031508) |
| 0.4 |
0.4 |
GO:0045583 |
regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
| 0.4 |
12.6 |
GO:0006101 |
citrate metabolic process(GO:0006101) |
| 0.4 |
1.9 |
GO:0032472 |
Golgi calcium ion transport(GO:0032472) |
| 0.4 |
1.5 |
GO:0016446 |
somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.4 |
4.2 |
GO:0000578 |
embryonic axis specification(GO:0000578) |
| 0.4 |
3.8 |
GO:0035116 |
embryonic hindlimb morphogenesis(GO:0035116) |
| 0.4 |
1.9 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.4 |
1.5 |
GO:0060155 |
platelet dense granule organization(GO:0060155) |
| 0.4 |
1.5 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.4 |
3.4 |
GO:0006337 |
nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
| 0.4 |
0.4 |
GO:0032200 |
telomere maintenance(GO:0000723) telomere organization(GO:0032200) |
| 0.4 |
0.4 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.4 |
0.7 |
GO:1904431 |
positive regulation of t-circle formation(GO:1904431) |
| 0.4 |
0.4 |
GO:2000010 |
positive regulation of protein localization to cell surface(GO:2000010) |
| 0.4 |
0.7 |
GO:0042364 |
water-soluble vitamin biosynthetic process(GO:0042364) |
| 0.4 |
1.1 |
GO:0030210 |
heparin biosynthetic process(GO:0030210) |
| 0.4 |
1.8 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.4 |
0.7 |
GO:0030222 |
eosinophil differentiation(GO:0030222) |
| 0.4 |
1.1 |
GO:2000675 |
regulation of type B pancreatic cell apoptotic process(GO:2000674) negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.4 |
1.1 |
GO:0042275 |
error-free postreplication DNA repair(GO:0042275) |
| 0.4 |
1.5 |
GO:2000195 |
negative regulation of female gonad development(GO:2000195) |
| 0.4 |
0.4 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.4 |
1.5 |
GO:0006297 |
nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.4 |
1.4 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.4 |
1.1 |
GO:0021691 |
cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.4 |
2.2 |
GO:0098700 |
aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.4 |
0.4 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.4 |
5.4 |
GO:0006825 |
copper ion transport(GO:0006825) |
| 0.4 |
1.1 |
GO:2000304 |
positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.4 |
1.1 |
GO:0097491 |
trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
| 0.4 |
1.1 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 0.4 |
0.4 |
GO:0044340 |
canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
| 0.4 |
3.2 |
GO:0046036 |
CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
| 0.4 |
2.5 |
GO:0032534 |
regulation of microvillus assembly(GO:0032534) |
| 0.4 |
1.8 |
GO:0031145 |
anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.4 |
3.5 |
GO:2000036 |
regulation of stem cell population maintenance(GO:2000036) |
| 0.4 |
2.8 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.4 |
1.1 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.4 |
1.4 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.4 |
0.4 |
GO:0070234 |
positive regulation of T cell apoptotic process(GO:0070234) |
| 0.4 |
2.8 |
GO:0045019 |
negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
| 0.4 |
1.4 |
GO:2000676 |
positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.3 |
7.6 |
GO:0009299 |
mRNA transcription(GO:0009299) |
| 0.3 |
0.3 |
GO:0048663 |
neuron fate commitment(GO:0048663) |
| 0.3 |
2.1 |
GO:0009249 |
protein lipoylation(GO:0009249) |
| 0.3 |
3.8 |
GO:0030953 |
astral microtubule organization(GO:0030953) |
| 0.3 |
2.1 |
GO:0001771 |
immunological synapse formation(GO:0001771) |
| 0.3 |
0.3 |
GO:1902263 |
apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
| 0.3 |
0.7 |
GO:2000418 |
positive regulation of eosinophil migration(GO:2000418) |
| 0.3 |
1.0 |
GO:1903048 |
regulation of acetylcholine-gated cation channel activity(GO:1903048) |
| 0.3 |
1.0 |
GO:0010940 |
positive regulation of necrotic cell death(GO:0010940) |
| 0.3 |
1.7 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.3 |
1.4 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.3 |
5.8 |
GO:0010718 |
positive regulation of epithelial to mesenchymal transition(GO:0010718) |
| 0.3 |
5.1 |
GO:0016973 |
poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.3 |
2.4 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.3 |
1.0 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.3 |
1.7 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.3 |
1.7 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 0.3 |
1.3 |
GO:0060346 |
bone trabecula formation(GO:0060346) |
| 0.3 |
0.7 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.3 |
1.3 |
GO:0042447 |
hormone catabolic process(GO:0042447) |
| 0.3 |
0.7 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
| 0.3 |
0.3 |
GO:1900368 |
regulation of RNA interference(GO:1900368) |
| 0.3 |
0.3 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.3 |
1.3 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.3 |
2.6 |
GO:0035112 |
genitalia morphogenesis(GO:0035112) |
| 0.3 |
0.7 |
GO:0035928 |
rRNA import into mitochondrion(GO:0035928) |
| 0.3 |
0.7 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.3 |
3.9 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
| 0.3 |
6.5 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.3 |
11.4 |
GO:0030835 |
negative regulation of actin filament depolymerization(GO:0030835) |
| 0.3 |
0.3 |
GO:0000305 |
response to oxygen radical(GO:0000305) |
| 0.3 |
0.3 |
GO:0090035 |
regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 0.3 |
0.6 |
GO:2000819 |
regulation of nucleotide-excision repair(GO:2000819) |
| 0.3 |
1.3 |
GO:0018065 |
protein-cofactor linkage(GO:0018065) |
| 0.3 |
1.6 |
GO:0061032 |
visceral serous pericardium development(GO:0061032) |
| 0.3 |
2.6 |
GO:1900121 |
negative regulation of receptor binding(GO:1900121) |
| 0.3 |
0.3 |
GO:0008295 |
spermidine biosynthetic process(GO:0008295) |
| 0.3 |
1.0 |
GO:0090274 |
positive regulation of somatostatin secretion(GO:0090274) |
| 0.3 |
3.8 |
GO:0038063 |
collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.3 |
1.3 |
GO:0019321 |
pentose metabolic process(GO:0019321) |
| 0.3 |
0.3 |
GO:0034035 |
purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
| 0.3 |
0.9 |
GO:1902219 |
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.3 |
0.6 |
GO:0046697 |
decidualization(GO:0046697) |
| 0.3 |
0.6 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.3 |
2.5 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.3 |
1.2 |
GO:0061052 |
negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
| 0.3 |
0.9 |
GO:0021764 |
amygdala development(GO:0021764) |
| 0.3 |
1.9 |
GO:0000963 |
mitochondrial RNA processing(GO:0000963) |
| 0.3 |
6.2 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.3 |
1.2 |
GO:1904008 |
cellular response to salt(GO:1902075) response to monosodium glutamate(GO:1904008) cellular response to monosodium glutamate(GO:1904009) |
| 0.3 |
1.2 |
GO:0003365 |
establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.3 |
0.3 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.3 |
9.1 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.3 |
2.1 |
GO:1903069 |
regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
| 0.3 |
2.1 |
GO:0006924 |
activation-induced cell death of T cells(GO:0006924) |
| 0.3 |
0.3 |
GO:0033313 |
meiotic cell cycle checkpoint(GO:0033313) |
| 0.3 |
2.7 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.3 |
2.4 |
GO:0045003 |
DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.3 |
3.0 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.3 |
0.9 |
GO:0042256 |
mature ribosome assembly(GO:0042256) |
| 0.3 |
0.3 |
GO:0072338 |
creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
| 0.3 |
0.3 |
GO:0035562 |
negative regulation of chromatin binding(GO:0035562) |
| 0.3 |
14.0 |
GO:0022900 |
electron transport chain(GO:0022900) |
| 0.3 |
0.6 |
GO:0072610 |
interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.3 |
0.3 |
GO:0006356 |
regulation of transcription from RNA polymerase I promoter(GO:0006356) |
| 0.3 |
1.2 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.3 |
0.6 |
GO:0072697 |
protein localization to cell cortex(GO:0072697) |
| 0.3 |
0.9 |
GO:0009644 |
response to high light intensity(GO:0009644) |
| 0.3 |
0.9 |
GO:0032717 |
negative regulation of interleukin-8 production(GO:0032717) |
| 0.3 |
2.1 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.3 |
1.2 |
GO:1903624 |
regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
| 0.3 |
3.5 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.3 |
0.6 |
GO:0045650 |
negative regulation of macrophage differentiation(GO:0045650) |
| 0.3 |
0.3 |
GO:0060455 |
regulation of gastric acid secretion(GO:0060453) negative regulation of gastric acid secretion(GO:0060455) |
| 0.3 |
1.7 |
GO:1902897 |
regulation of postsynaptic density protein 95 clustering(GO:1902897) |
| 0.3 |
0.9 |
GO:0030647 |
polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.3 |
1.7 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.3 |
2.9 |
GO:0006370 |
7-methylguanosine mRNA capping(GO:0006370) |
| 0.3 |
0.3 |
GO:0043504 |
mitochondrial DNA repair(GO:0043504) |
| 0.3 |
1.7 |
GO:0030578 |
PML body organization(GO:0030578) |
| 0.3 |
2.0 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
| 0.3 |
0.6 |
GO:0055070 |
copper ion homeostasis(GO:0055070) |
| 0.3 |
0.3 |
GO:0071599 |
otic vesicle development(GO:0071599) otic vesicle morphogenesis(GO:0071600) |
| 0.3 |
0.3 |
GO:0030656 |
regulation of vitamin metabolic process(GO:0030656) |
| 0.3 |
0.9 |
GO:0006167 |
AMP biosynthetic process(GO:0006167) |
| 0.3 |
0.9 |
GO:0090038 |
negative regulation of protein kinase C signaling(GO:0090038) |
| 0.3 |
0.8 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.3 |
1.7 |
GO:0032786 |
positive regulation of DNA-templated transcription, elongation(GO:0032786) |
| 0.3 |
1.4 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.3 |
4.5 |
GO:0000470 |
maturation of LSU-rRNA(GO:0000470) |
| 0.3 |
1.1 |
GO:0046391 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.3 |
1.7 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.3 |
0.6 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.3 |
2.2 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
| 0.3 |
8.1 |
GO:0000462 |
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.3 |
0.6 |
GO:0006977 |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 0.3 |
7.0 |
GO:0035458 |
cellular response to interferon-beta(GO:0035458) |
| 0.3 |
0.8 |
GO:0070127 |
tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.3 |
2.2 |
GO:0006098 |
pentose-phosphate shunt(GO:0006098) |
| 0.3 |
10.3 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.3 |
0.6 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.3 |
1.7 |
GO:0000212 |
meiotic spindle organization(GO:0000212) |
| 0.3 |
1.1 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.3 |
2.2 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.3 |
1.9 |
GO:2000258 |
negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
| 0.3 |
0.3 |
GO:0070417 |
cellular response to cold(GO:0070417) |
| 0.3 |
0.5 |
GO:0035729 |
response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
| 0.3 |
1.1 |
GO:0046602 |
regulation of mitotic centrosome separation(GO:0046602) |
| 0.3 |
0.5 |
GO:0030225 |
macrophage differentiation(GO:0030225) |
| 0.3 |
1.4 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.3 |
0.3 |
GO:2000279 |
negative regulation of DNA biosynthetic process(GO:2000279) |
| 0.3 |
1.1 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.3 |
0.8 |
GO:0051156 |
glucose 6-phosphate metabolic process(GO:0051156) |
| 0.3 |
1.3 |
GO:0019471 |
4-hydroxyproline metabolic process(GO:0019471) |
| 0.3 |
3.8 |
GO:0042273 |
ribosomal large subunit biogenesis(GO:0042273) |
| 0.3 |
4.5 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.3 |
3.7 |
GO:0035518 |
histone H2A monoubiquitination(GO:0035518) |
| 0.3 |
1.1 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.3 |
1.3 |
GO:0071679 |
commissural neuron axon guidance(GO:0071679) |
| 0.3 |
1.8 |
GO:0018126 |
protein hydroxylation(GO:0018126) |
| 0.3 |
0.3 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.3 |
0.5 |
GO:0010838 |
positive regulation of keratinocyte proliferation(GO:0010838) |
| 0.3 |
0.5 |
GO:0051031 |
tRNA transport(GO:0051031) |
| 0.3 |
0.5 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.3 |
2.1 |
GO:2000251 |
positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.3 |
1.8 |
GO:0036297 |
interstrand cross-link repair(GO:0036297) |
| 0.3 |
2.8 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.3 |
0.8 |
GO:0050859 |
negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.3 |
0.8 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.3 |
2.3 |
GO:0051352 |
negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
| 0.3 |
3.1 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.3 |
0.8 |
GO:0001193 |
maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
| 0.3 |
0.5 |
GO:0033683 |
nucleotide-excision repair, DNA incision(GO:0033683) |
| 0.3 |
3.5 |
GO:0046855 |
phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
| 0.3 |
0.5 |
GO:0006481 |
C-terminal protein methylation(GO:0006481) |
| 0.2 |
1.0 |
GO:0018158 |
protein oxidation(GO:0018158) |
| 0.2 |
1.7 |
GO:2000643 |
positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.2 |
1.7 |
GO:0045040 |
outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) establishment of protein localization to mitochondrial membrane(GO:0090151) |
| 0.2 |
0.2 |
GO:2000852 |
regulation of corticosterone secretion(GO:2000852) |
| 0.2 |
1.0 |
GO:1900533 |
medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.2 |
1.0 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.2 |
3.4 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.2 |
3.4 |
GO:0009988 |
cell-cell recognition(GO:0009988) |
| 0.2 |
1.9 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 0.2 |
1.7 |
GO:0034393 |
positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.2 |
0.5 |
GO:0030223 |
neutrophil differentiation(GO:0030223) |
| 0.2 |
4.8 |
GO:0000154 |
rRNA modification(GO:0000154) |
| 0.2 |
0.5 |
GO:0046013 |
regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.2 |
0.2 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 0.2 |
0.5 |
GO:0070243 |
regulation of thymocyte apoptotic process(GO:0070243) |
| 0.2 |
3.8 |
GO:0072673 |
lamellipodium morphogenesis(GO:0072673) |
| 0.2 |
0.7 |
GO:0042097 |
interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
| 0.2 |
0.9 |
GO:0038030 |
non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
| 0.2 |
0.2 |
GO:0044849 |
estrous cycle(GO:0044849) |
| 0.2 |
0.5 |
GO:0042482 |
positive regulation of odontogenesis(GO:0042482) |
| 0.2 |
0.7 |
GO:0000320 |
re-entry into mitotic cell cycle(GO:0000320) |
| 0.2 |
0.7 |
GO:1904729 |
regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal absorption(GO:1904478) regulation of intestinal lipid absorption(GO:1904729) |
| 0.2 |
0.5 |
GO:1900745 |
positive regulation of p38MAPK cascade(GO:1900745) |
| 0.2 |
2.1 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 0.2 |
0.9 |
GO:0071475 |
cellular hyperosmotic salinity response(GO:0071475) double-strand break repair via classical nonhomologous end joining(GO:0097680) |
| 0.2 |
0.7 |
GO:0021523 |
somatic motor neuron differentiation(GO:0021523) |
| 0.2 |
1.4 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.2 |
1.4 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.2 |
0.2 |
GO:1903599 |
positive regulation of mitophagy(GO:1903599) |
| 0.2 |
0.5 |
GO:0043201 |
response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
| 0.2 |
1.8 |
GO:0018916 |
nitrobenzene metabolic process(GO:0018916) |
| 0.2 |
0.7 |
GO:0033136 |
serine phosphorylation of STAT3 protein(GO:0033136) |
| 0.2 |
0.7 |
GO:0033314 |
mitotic DNA replication checkpoint(GO:0033314) |
| 0.2 |
0.7 |
GO:0042699 |
follicle-stimulating hormone signaling pathway(GO:0042699) |
| 0.2 |
0.2 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.2 |
1.1 |
GO:0035469 |
determination of pancreatic left/right asymmetry(GO:0035469) |
| 0.2 |
0.5 |
GO:0033262 |
regulation of nuclear cell cycle DNA replication(GO:0033262) |
| 0.2 |
2.7 |
GO:0048661 |
positive regulation of smooth muscle cell proliferation(GO:0048661) |
| 0.2 |
0.9 |
GO:0031047 |
gene silencing by RNA(GO:0031047) |
| 0.2 |
1.3 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.2 |
1.3 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.2 |
2.2 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.2 |
1.1 |
GO:0042178 |
xenobiotic catabolic process(GO:0042178) |
| 0.2 |
0.2 |
GO:1900242 |
regulation of synaptic vesicle endocytosis(GO:1900242) |
| 0.2 |
0.9 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.2 |
0.4 |
GO:1903301 |
regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
| 0.2 |
1.1 |
GO:0060716 |
labyrinthine layer blood vessel development(GO:0060716) |
| 0.2 |
0.9 |
GO:0018202 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
| 0.2 |
0.7 |
GO:0046032 |
ADP catabolic process(GO:0046032) |
| 0.2 |
0.2 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 0.2 |
1.3 |
GO:0042769 |
DNA damage response, detection of DNA damage(GO:0042769) |
| 0.2 |
0.2 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.2 |
0.9 |
GO:0051085 |
chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.2 |
0.6 |
GO:0002669 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.2 |
1.3 |
GO:1903847 |
regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
| 0.2 |
0.4 |
GO:0002082 |
regulation of oxidative phosphorylation(GO:0002082) |
| 0.2 |
0.9 |
GO:0035067 |
negative regulation of histone acetylation(GO:0035067) |
| 0.2 |
4.3 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.2 |
0.6 |
GO:0016242 |
negative regulation of macroautophagy(GO:0016242) |
| 0.2 |
0.2 |
GO:0033292 |
T-tubule organization(GO:0033292) |
| 0.2 |
0.8 |
GO:1904668 |
positive regulation of ubiquitin protein ligase activity(GO:1904668) |
| 0.2 |
0.8 |
GO:0045945 |
positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.2 |
0.6 |
GO:0006591 |
ornithine metabolic process(GO:0006591) |
| 0.2 |
0.8 |
GO:0016556 |
mRNA modification(GO:0016556) |
| 0.2 |
0.8 |
GO:0001711 |
endodermal cell fate commitment(GO:0001711) |
| 0.2 |
0.6 |
GO:0002755 |
MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
| 0.2 |
0.8 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.2 |
0.8 |
GO:0031860 |
telomeric 3' overhang formation(GO:0031860) |
| 0.2 |
0.6 |
GO:0040037 |
negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
| 0.2 |
0.6 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 0.2 |
1.4 |
GO:0042790 |
transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
| 0.2 |
2.1 |
GO:0021854 |
hypothalamus development(GO:0021854) |
| 0.2 |
0.6 |
GO:0006428 |
isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.2 |
1.8 |
GO:2000269 |
regulation of fibroblast apoptotic process(GO:2000269) |
| 0.2 |
0.4 |
GO:0014873 |
response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
| 0.2 |
1.8 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.2 |
0.8 |
GO:0032211 |
negative regulation of telomere maintenance via telomerase(GO:0032211) |
| 0.2 |
1.2 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.2 |
9.5 |
GO:0006611 |
protein export from nucleus(GO:0006611) |
| 0.2 |
0.2 |
GO:0021593 |
rhombomere morphogenesis(GO:0021593) |
| 0.2 |
1.4 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.2 |
0.4 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.2 |
1.2 |
GO:0051231 |
mitotic spindle elongation(GO:0000022) spindle elongation(GO:0051231) spindle midzone assembly(GO:0051255) mitotic spindle midzone assembly(GO:0051256) |
| 0.2 |
0.6 |
GO:0051123 |
RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
| 0.2 |
0.6 |
GO:0031915 |
positive regulation of synaptic plasticity(GO:0031915) |
| 0.2 |
0.8 |
GO:0032511 |
late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.2 |
0.6 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.2 |
1.2 |
GO:0010664 |
negative regulation of striated muscle cell apoptotic process(GO:0010664) |
| 0.2 |
0.4 |
GO:0032513 |
negative regulation of protein phosphatase type 2B activity(GO:0032513) |
| 0.2 |
0.4 |
GO:1904251 |
regulation of bile acid metabolic process(GO:1904251) |
| 0.2 |
0.2 |
GO:0070970 |
interleukin-2 secretion(GO:0070970) regulation of interleukin-2 secretion(GO:1900040) |
| 0.2 |
1.0 |
GO:0034397 |
telomere localization(GO:0034397) |
| 0.2 |
0.6 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.2 |
1.0 |
GO:0010226 |
response to lithium ion(GO:0010226) |
| 0.2 |
3.8 |
GO:0048025 |
negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.2 |
0.9 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.2 |
0.2 |
GO:0002314 |
germinal center B cell differentiation(GO:0002314) |
| 0.2 |
2.1 |
GO:0050765 |
negative regulation of phagocytosis(GO:0050765) |
| 0.2 |
1.1 |
GO:0002693 |
positive regulation of cellular extravasation(GO:0002693) |
| 0.2 |
0.8 |
GO:0019370 |
leukotriene biosynthetic process(GO:0019370) |
| 0.2 |
1.9 |
GO:0002097 |
tRNA wobble base modification(GO:0002097) |
| 0.2 |
0.4 |
GO:1903378 |
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.2 |
0.4 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.2 |
5.2 |
GO:2000816 |
negative regulation of mitotic metaphase/anaphase transition(GO:0045841) mitotic spindle checkpoint(GO:0071174) negative regulation of metaphase/anaphase transition of cell cycle(GO:1902100) negative regulation of mitotic sister chromatid separation(GO:2000816) |
| 0.2 |
0.6 |
GO:0071670 |
smooth muscle cell chemotaxis(GO:0071670) |
| 0.2 |
2.4 |
GO:0042149 |
cellular response to glucose starvation(GO:0042149) |
| 0.2 |
0.2 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 0.2 |
0.4 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.2 |
1.8 |
GO:0043403 |
skeletal muscle tissue regeneration(GO:0043403) |
| 0.2 |
0.2 |
GO:0048239 |
negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
| 0.2 |
0.9 |
GO:0042541 |
hemoglobin biosynthetic process(GO:0042541) |
| 0.2 |
1.1 |
GO:0071380 |
cellular response to prostaglandin stimulus(GO:0071379) cellular response to prostaglandin E stimulus(GO:0071380) |
| 0.2 |
0.5 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 0.2 |
0.4 |
GO:0010886 |
positive regulation of cholesterol storage(GO:0010886) |
| 0.2 |
0.5 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.2 |
0.4 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.2 |
0.2 |
GO:0097151 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.2 |
1.4 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.2 |
1.4 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
| 0.2 |
0.7 |
GO:0034379 |
very-low-density lipoprotein particle assembly(GO:0034379) |
| 0.2 |
2.3 |
GO:0030574 |
collagen catabolic process(GO:0030574) |
| 0.2 |
2.9 |
GO:0045070 |
positive regulation of viral genome replication(GO:0045070) |
| 0.2 |
3.0 |
GO:0016574 |
histone ubiquitination(GO:0016574) |
| 0.2 |
0.2 |
GO:0032466 |
negative regulation of cytokinesis(GO:0032466) |
| 0.2 |
0.9 |
GO:0035022 |
positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.2 |
0.2 |
GO:0035898 |
parathyroid hormone secretion(GO:0035898) |
| 0.2 |
0.5 |
GO:1904816 |
regulation of protein localization to chromosome, telomeric region(GO:1904814) positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
| 0.2 |
0.2 |
GO:0072194 |
kidney smooth muscle tissue development(GO:0072194) |
| 0.2 |
0.2 |
GO:0021957 |
corticospinal tract morphogenesis(GO:0021957) |
| 0.2 |
1.4 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.2 |
1.2 |
GO:0034244 |
negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.2 |
7.9 |
GO:0051028 |
mRNA transport(GO:0051028) |
| 0.2 |
1.7 |
GO:0048680 |
positive regulation of axon regeneration(GO:0048680) |
| 0.2 |
0.9 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 0.2 |
2.3 |
GO:0033235 |
positive regulation of protein sumoylation(GO:0033235) |
| 0.2 |
0.7 |
GO:0044351 |
macropinocytosis(GO:0044351) |
| 0.2 |
2.9 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
| 0.2 |
0.7 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.2 |
0.2 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.2 |
2.9 |
GO:0042753 |
positive regulation of circadian rhythm(GO:0042753) |
| 0.2 |
0.9 |
GO:0071346 |
cellular response to interferon-gamma(GO:0071346) |
| 0.2 |
0.5 |
GO:0072176 |
nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
| 0.2 |
0.7 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.2 |
1.0 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.2 |
0.5 |
GO:0000087 |
mitotic M phase(GO:0000087) mitotic cell cycle phase(GO:0098763) |
| 0.2 |
3.6 |
GO:0031397 |
negative regulation of protein ubiquitination(GO:0031397) |
| 0.2 |
0.5 |
GO:0015938 |
coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
| 0.2 |
0.8 |
GO:0042359 |
vitamin D metabolic process(GO:0042359) |
| 0.2 |
0.2 |
GO:0000972 |
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 0.2 |
0.8 |
GO:1900016 |
negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.2 |
0.3 |
GO:0042059 |
negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
| 0.2 |
1.8 |
GO:0010971 |
positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) positive regulation of cell cycle G2/M phase transition(GO:1902751) |
| 0.2 |
0.8 |
GO:1903689 |
regulation of wound healing, spreading of epidermal cells(GO:1903689) negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.2 |
2.0 |
GO:0030261 |
chromosome condensation(GO:0030261) |
| 0.2 |
2.0 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.2 |
0.3 |
GO:0045717 |
negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.2 |
1.2 |
GO:0016560 |
protein import into peroxisome matrix, docking(GO:0016560) |
| 0.2 |
0.5 |
GO:0046381 |
CMP-N-acetylneuraminate metabolic process(GO:0046381) |
| 0.2 |
0.5 |
GO:0002014 |
vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
| 0.2 |
1.9 |
GO:0008340 |
determination of adult lifespan(GO:0008340) |
| 0.2 |
0.2 |
GO:0071035 |
polyadenylation-dependent ncRNA catabolic process(GO:0043634) nuclear ncRNA surveillance(GO:0071029) nuclear polyadenylation-dependent rRNA catabolic process(GO:0071035) nuclear polyadenylation-dependent ncRNA catabolic process(GO:0071046) |
| 0.2 |
12.0 |
GO:0042254 |
ribosome biogenesis(GO:0042254) |
| 0.2 |
1.3 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.2 |
0.5 |
GO:0048333 |
mesodermal cell differentiation(GO:0048333) |
| 0.2 |
0.8 |
GO:0006451 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.2 |
0.5 |
GO:0046016 |
regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
| 0.2 |
0.2 |
GO:0061009 |
common bile duct development(GO:0061009) |
| 0.2 |
0.5 |
GO:0097401 |
synaptic vesicle lumen acidification(GO:0097401) |
| 0.2 |
0.6 |
GO:0075522 |
IRES-dependent viral translational initiation(GO:0075522) |
| 0.2 |
3.8 |
GO:0002181 |
cytoplasmic translation(GO:0002181) |
| 0.2 |
0.6 |
GO:1904715 |
negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.2 |
0.6 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 0.2 |
0.3 |
GO:0032202 |
telomere assembly(GO:0032202) |
| 0.2 |
0.8 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) negative regulation of neutrophil activation(GO:1902564) |
| 0.2 |
2.7 |
GO:0006743 |
ubiquinone metabolic process(GO:0006743) |
| 0.2 |
5.6 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.2 |
0.6 |
GO:0043628 |
ncRNA 3'-end processing(GO:0043628) |
| 0.2 |
0.2 |
GO:1902237 |
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
| 0.2 |
1.4 |
GO:0043249 |
erythrocyte maturation(GO:0043249) |
| 0.2 |
0.2 |
GO:0031033 |
myosin filament organization(GO:0031033) |
| 0.2 |
0.5 |
GO:0051792 |
medium-chain fatty acid biosynthetic process(GO:0051792) |
| 0.2 |
2.0 |
GO:0060445 |
branching involved in salivary gland morphogenesis(GO:0060445) |
| 0.2 |
0.2 |
GO:0002903 |
negative regulation of B cell apoptotic process(GO:0002903) |
| 0.2 |
1.5 |
GO:0006560 |
proline metabolic process(GO:0006560) |
| 0.2 |
0.6 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.2 |
0.3 |
GO:1904395 |
positive regulation of receptor clustering(GO:1903911) regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
| 0.2 |
1.4 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
| 0.2 |
1.2 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.2 |
1.7 |
GO:2000249 |
regulation of actin cytoskeleton reorganization(GO:2000249) |
| 0.1 |
0.4 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.1 |
1.3 |
GO:0001706 |
endoderm formation(GO:0001706) |
| 0.1 |
0.1 |
GO:0030202 |
heparin metabolic process(GO:0030202) |
| 0.1 |
1.0 |
GO:0048845 |
venous blood vessel morphogenesis(GO:0048845) |
| 0.1 |
3.3 |
GO:0009060 |
aerobic respiration(GO:0009060) |
| 0.1 |
0.4 |
GO:0030853 |
negative regulation of granulocyte differentiation(GO:0030853) |
| 0.1 |
0.3 |
GO:0003211 |
cardiac ventricle formation(GO:0003211) |
| 0.1 |
1.6 |
GO:0035646 |
endosome to melanosome transport(GO:0035646) pigment accumulation(GO:0043476) cellular pigment accumulation(GO:0043482) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
| 0.1 |
0.3 |
GO:0060623 |
regulation of chromosome condensation(GO:0060623) |
| 0.1 |
10.4 |
GO:0008033 |
tRNA processing(GO:0008033) |
| 0.1 |
0.6 |
GO:0048873 |
homeostasis of number of cells within a tissue(GO:0048873) |
| 0.1 |
1.6 |
GO:0035025 |
positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.1 |
0.6 |
GO:1902745 |
positive regulation of lamellipodium organization(GO:1902745) |
| 0.1 |
1.3 |
GO:0048844 |
artery morphogenesis(GO:0048844) |
| 0.1 |
1.7 |
GO:0032526 |
response to retinoic acid(GO:0032526) |
| 0.1 |
1.7 |
GO:0042347 |
negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.1 |
1.4 |
GO:0006490 |
oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.1 |
0.3 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.1 |
0.3 |
GO:2000286 |
receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.1 |
0.3 |
GO:0007320 |
insemination(GO:0007320) |
| 0.1 |
0.1 |
GO:0006667 |
sphinganine metabolic process(GO:0006667) |
| 0.1 |
0.4 |
GO:0033615 |
mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.1 |
0.4 |
GO:0051030 |
snRNA transport(GO:0051030) |
| 0.1 |
0.1 |
GO:0001844 |
protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
| 0.1 |
4.4 |
GO:0000380 |
alternative mRNA splicing, via spliceosome(GO:0000380) |
| 0.1 |
0.4 |
GO:0021800 |
cerebral cortex tangential migration(GO:0021800) |
| 0.1 |
1.5 |
GO:0034312 |
diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
| 0.1 |
0.3 |
GO:1903861 |
regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 0.1 |
1.8 |
GO:0030513 |
positive regulation of BMP signaling pathway(GO:0030513) |
| 0.1 |
1.7 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
| 0.1 |
0.1 |
GO:1904263 |
positive regulation of TORC1 signaling(GO:1904263) |
| 0.1 |
0.3 |
GO:0015920 |
lipopolysaccharide transport(GO:0015920) |
| 0.1 |
0.4 |
GO:0000076 |
DNA replication checkpoint(GO:0000076) |
| 0.1 |
0.5 |
GO:0010719 |
negative regulation of epithelial to mesenchymal transition(GO:0010719) |
| 0.1 |
0.3 |
GO:0042373 |
vitamin K metabolic process(GO:0042373) |
| 0.1 |
0.7 |
GO:0070365 |
hepatocyte differentiation(GO:0070365) |
| 0.1 |
0.3 |
GO:1902031 |
regulation of NADP metabolic process(GO:1902031) |
| 0.1 |
1.3 |
GO:2001256 |
regulation of store-operated calcium entry(GO:2001256) |
| 0.1 |
1.7 |
GO:0006289 |
nucleotide-excision repair(GO:0006289) |
| 0.1 |
1.1 |
GO:0009143 |
nucleoside triphosphate catabolic process(GO:0009143) |
| 0.1 |
0.5 |
GO:0071839 |
apoptotic process in bone marrow(GO:0071839) |
| 0.1 |
1.8 |
GO:0030497 |
fatty acid elongation(GO:0030497) |
| 0.1 |
0.1 |
GO:2000298 |
regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.1 |
1.2 |
GO:0019886 |
antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
| 0.1 |
0.4 |
GO:1900117 |
regulation of execution phase of apoptosis(GO:1900117) |
| 0.1 |
0.9 |
GO:0035090 |
maintenance of apical/basal cell polarity(GO:0035090) |
| 0.1 |
0.7 |
GO:0048537 |
mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
| 0.1 |
1.2 |
GO:0021510 |
spinal cord development(GO:0021510) |
| 0.1 |
1.3 |
GO:0030213 |
hyaluronan biosynthetic process(GO:0030213) |
| 0.1 |
0.3 |
GO:0001788 |
antibody-dependent cellular cytotoxicity(GO:0001788) |
| 0.1 |
0.4 |
GO:0030277 |
maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.1 |
0.6 |
GO:0051569 |
regulation of histone H3-K4 methylation(GO:0051569) |
| 0.1 |
1.0 |
GO:0030238 |
male sex determination(GO:0030238) |
| 0.1 |
0.3 |
GO:0060330 |
regulation of response to interferon-gamma(GO:0060330) |
| 0.1 |
0.4 |
GO:0050850 |
positive regulation of calcium-mediated signaling(GO:0050850) |
| 0.1 |
0.4 |
GO:0002183 |
cytoplasmic translational initiation(GO:0002183) |
| 0.1 |
0.6 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.1 |
0.4 |
GO:0046668 |
retinal cell programmed cell death(GO:0046666) regulation of retinal cell programmed cell death(GO:0046668) |
| 0.1 |
0.2 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.1 |
0.7 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.1 |
1.0 |
GO:0035510 |
DNA dealkylation(GO:0035510) |
| 0.1 |
8.1 |
GO:1903955 |
positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.1 |
0.5 |
GO:1900118 |
negative regulation of execution phase of apoptosis(GO:1900118) |
| 0.1 |
0.9 |
GO:1904031 |
positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
| 0.1 |
0.5 |
GO:1905098 |
negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.1 |
1.0 |
GO:0002467 |
germinal center formation(GO:0002467) |
| 0.1 |
0.1 |
GO:0048484 |
enteric nervous system development(GO:0048484) |
| 0.1 |
0.1 |
GO:0010155 |
regulation of proton transport(GO:0010155) |
| 0.1 |
0.4 |
GO:0060766 |
negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.1 |
14.5 |
GO:0000375 |
RNA splicing, via transesterification reactions(GO:0000375) |
| 0.1 |
0.4 |
GO:0045075 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.1 |
1.0 |
GO:0006308 |
DNA catabolic process(GO:0006308) |
| 0.1 |
0.2 |
GO:0010626 |
negative regulation of Schwann cell proliferation(GO:0010626) |
| 0.1 |
0.5 |
GO:0007184 |
SMAD protein import into nucleus(GO:0007184) |
| 0.1 |
0.2 |
GO:0051573 |
negative regulation of histone H3-K9 methylation(GO:0051573) |
| 0.1 |
0.4 |
GO:1902047 |
polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.1 |
0.6 |
GO:0070327 |
thyroid hormone metabolic process(GO:0042403) thyroid hormone transport(GO:0070327) |
| 0.1 |
0.4 |
GO:1902036 |
regulation of hematopoietic stem cell differentiation(GO:1902036) |
| 0.1 |
0.4 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 0.1 |
1.8 |
GO:0006221 |
pyrimidine nucleotide biosynthetic process(GO:0006221) |
| 0.1 |
3.2 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.1 |
0.5 |
GO:0016601 |
Rac protein signal transduction(GO:0016601) |
| 0.1 |
0.9 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 0.1 |
0.3 |
GO:0090037 |
positive regulation of protein kinase C signaling(GO:0090037) |
| 0.1 |
2.9 |
GO:0034605 |
cellular response to heat(GO:0034605) |
| 0.1 |
0.9 |
GO:0006573 |
valine metabolic process(GO:0006573) |
| 0.1 |
1.5 |
GO:0007213 |
G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.1 |
3.5 |
GO:1902017 |
regulation of cilium assembly(GO:1902017) |
| 0.1 |
0.2 |
GO:0060352 |
cell adhesion molecule production(GO:0060352) |
| 0.1 |
0.6 |
GO:0060452 |
positive regulation of cardiac muscle contraction(GO:0060452) |
| 0.1 |
0.6 |
GO:0090209 |
negative regulation of triglyceride metabolic process(GO:0090209) |
| 0.1 |
0.6 |
GO:1903146 |
regulation of mitophagy(GO:1903146) |
| 0.1 |
1.0 |
GO:0046677 |
response to antibiotic(GO:0046677) |
| 0.1 |
2.9 |
GO:0006418 |
tRNA aminoacylation for protein translation(GO:0006418) |
| 0.1 |
0.3 |
GO:0089700 |
protein kinase D signaling(GO:0089700) |
| 0.1 |
1.8 |
GO:0001736 |
establishment of planar polarity(GO:0001736) establishment of tissue polarity(GO:0007164) |
| 0.1 |
0.9 |
GO:1903960 |
negative regulation of anion transmembrane transport(GO:1903960) |
| 0.1 |
0.2 |
GO:0032276 |
regulation of gonadotropin secretion(GO:0032276) |
| 0.1 |
0.2 |
GO:0010986 |
positive regulation of lipoprotein particle clearance(GO:0010986) |
| 0.1 |
0.2 |
GO:0070782 |
phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
| 0.1 |
0.6 |
GO:0006930 |
substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.1 |
3.1 |
GO:0042168 |
heme metabolic process(GO:0042168) |
| 0.1 |
0.4 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.1 |
1.7 |
GO:0032981 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.1 |
0.9 |
GO:0046628 |
positive regulation of insulin receptor signaling pathway(GO:0046628) |
| 0.1 |
0.8 |
GO:0030224 |
monocyte differentiation(GO:0030224) |
| 0.1 |
0.4 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 0.1 |
0.1 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.1 |
0.9 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.1 |
0.3 |
GO:0015886 |
heme transport(GO:0015886) |
| 0.1 |
1.1 |
GO:0060236 |
regulation of mitotic spindle organization(GO:0060236) |
| 0.1 |
0.3 |
GO:0019478 |
D-amino acid catabolic process(GO:0019478) |
| 0.1 |
1.7 |
GO:0001959 |
regulation of cytokine-mediated signaling pathway(GO:0001959) |
| 0.1 |
0.2 |
GO:0043950 |
positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.1 |
0.8 |
GO:0016081 |
synaptic vesicle docking(GO:0016081) |
| 0.1 |
0.2 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.1 |
0.6 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
| 0.1 |
1.5 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.1 |
1.7 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.1 |
0.1 |
GO:0030812 |
negative regulation of nucleotide catabolic process(GO:0030812) negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 0.1 |
1.3 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.1 |
0.5 |
GO:0009396 |
folic acid-containing compound biosynthetic process(GO:0009396) |
| 0.1 |
3.5 |
GO:0043966 |
histone H3 acetylation(GO:0043966) |
| 0.1 |
0.5 |
GO:0071157 |
negative regulation of cell cycle arrest(GO:0071157) |
| 0.1 |
0.4 |
GO:0035358 |
regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035358) |
| 0.1 |
0.5 |
GO:1903392 |
negative regulation of adherens junction organization(GO:1903392) |
| 0.1 |
0.2 |
GO:1900107 |
regulation of nodal signaling pathway(GO:1900107) |
| 0.1 |
0.8 |
GO:0002931 |
response to ischemia(GO:0002931) |
| 0.1 |
0.5 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.1 |
0.3 |
GO:0042474 |
middle ear morphogenesis(GO:0042474) |
| 0.1 |
0.8 |
GO:0035845 |
photoreceptor cell outer segment organization(GO:0035845) |
| 0.1 |
0.9 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.1 |
0.3 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.1 |
0.6 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.1 |
5.3 |
GO:0006413 |
translational initiation(GO:0006413) |
| 0.1 |
0.4 |
GO:0006826 |
iron ion transport(GO:0006826) |
| 0.1 |
0.4 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) isopentenyl diphosphate metabolic process(GO:0046490) |
| 0.1 |
0.1 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.1 |
5.8 |
GO:0006334 |
nucleosome assembly(GO:0006334) |
| 0.1 |
0.2 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.1 |
0.4 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 0.1 |
0.3 |
GO:0016233 |
telomere capping(GO:0016233) |
| 0.1 |
0.5 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.1 |
0.7 |
GO:0035437 |
maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.1 |
0.1 |
GO:0000414 |
regulation of histone H3-K36 methylation(GO:0000414) |
| 0.1 |
0.5 |
GO:0090344 |
negative regulation of cell aging(GO:0090344) |
| 0.1 |
1.1 |
GO:0097202 |
activation of cysteine-type endopeptidase activity(GO:0097202) |
| 0.1 |
0.3 |
GO:0034638 |
phosphatidylcholine catabolic process(GO:0034638) |
| 0.1 |
0.5 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.1 |
1.3 |
GO:0045747 |
positive regulation of Notch signaling pathway(GO:0045747) |
| 0.1 |
0.3 |
GO:0030208 |
dermatan sulfate biosynthetic process(GO:0030208) |
| 0.1 |
0.7 |
GO:0002088 |
lens development in camera-type eye(GO:0002088) |
| 0.1 |
0.4 |
GO:0071236 |
cellular response to antibiotic(GO:0071236) |
| 0.1 |
0.5 |
GO:0006301 |
postreplication repair(GO:0006301) |
| 0.1 |
0.4 |
GO:0050892 |
intestinal absorption(GO:0050892) |
| 0.1 |
0.8 |
GO:0007080 |
mitotic metaphase plate congression(GO:0007080) |
| 0.1 |
0.8 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.1 |
0.7 |
GO:0006517 |
protein deglycosylation(GO:0006517) |
| 0.1 |
0.2 |
GO:0008630 |
intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
| 0.1 |
0.2 |
GO:2000381 |
negative regulation of mesoderm development(GO:2000381) |
| 0.1 |
0.1 |
GO:0032847 |
regulation of cellular pH reduction(GO:0032847) |
| 0.1 |
0.8 |
GO:0097178 |
ruffle assembly(GO:0097178) |
| 0.1 |
0.3 |
GO:0050779 |
RNA destabilization(GO:0050779) |
| 0.1 |
1.1 |
GO:2001222 |
regulation of neuron migration(GO:2001222) |
| 0.1 |
0.3 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.1 |
2.3 |
GO:0042771 |
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.1 |
0.3 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.1 |
0.2 |
GO:0052428 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.1 |
2.2 |
GO:0000725 |
double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
| 0.1 |
0.2 |
GO:2000192 |
negative regulation of fatty acid transport(GO:2000192) |
| 0.1 |
0.2 |
GO:0042730 |
fibrinolysis(GO:0042730) |
| 0.1 |
0.3 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.1 |
0.1 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 0.1 |
0.4 |
GO:0071294 |
cellular response to zinc ion(GO:0071294) |
| 0.1 |
0.2 |
GO:0051036 |
regulation of endosome size(GO:0051036) |
| 0.1 |
0.6 |
GO:0001658 |
branching involved in ureteric bud morphogenesis(GO:0001658) |
| 0.1 |
0.6 |
GO:0051988 |
regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.1 |
0.4 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.1 |
1.6 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
| 0.1 |
0.4 |
GO:0001890 |
placenta development(GO:0001890) |
| 0.1 |
0.3 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.1 |
1.0 |
GO:0016925 |
protein sumoylation(GO:0016925) |
| 0.1 |
0.3 |
GO:0060177 |
regulation of angiotensin metabolic process(GO:0060177) |
| 0.1 |
0.7 |
GO:0060055 |
angiogenesis involved in wound healing(GO:0060055) |
| 0.1 |
0.9 |
GO:0034198 |
cellular response to amino acid starvation(GO:0034198) |
| 0.1 |
0.1 |
GO:0051503 |
adenine nucleotide transport(GO:0051503) |
| 0.1 |
0.3 |
GO:0097284 |
hepatocyte apoptotic process(GO:0097284) |
| 0.1 |
0.3 |
GO:0072584 |
caveolin-mediated endocytosis(GO:0072584) |
| 0.1 |
0.1 |
GO:0035357 |
peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
| 0.1 |
0.2 |
GO:0072017 |
distal tubule development(GO:0072017) |
| 0.1 |
0.9 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.1 |
0.4 |
GO:0046599 |
regulation of centriole replication(GO:0046599) |
| 0.1 |
0.2 |
GO:0043312 |
neutrophil degranulation(GO:0043312) |
| 0.1 |
0.1 |
GO:0010666 |
positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.1 |
0.9 |
GO:0008214 |
protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
| 0.1 |
0.6 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
| 0.1 |
1.6 |
GO:0048013 |
ephrin receptor signaling pathway(GO:0048013) |
| 0.1 |
0.1 |
GO:0061724 |
lipophagy(GO:0061724) |
| 0.1 |
0.3 |
GO:0060670 |
branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.1 |
0.1 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.1 |
0.3 |
GO:0009068 |
aspartate family amino acid catabolic process(GO:0009068) |
| 0.1 |
0.4 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.1 |
0.4 |
GO:0046040 |
IMP metabolic process(GO:0046040) |
| 0.1 |
0.5 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.1 |
0.2 |
GO:0097089 |
methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.1 |
0.1 |
GO:0048701 |
embryonic cranial skeleton morphogenesis(GO:0048701) |
| 0.1 |
0.6 |
GO:0008625 |
extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) |
| 0.1 |
0.4 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
| 0.1 |
0.6 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.1 |
1.9 |
GO:0032543 |
mitochondrial translation(GO:0032543) |
| 0.1 |
0.1 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.1 |
0.5 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.1 |
0.1 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.1 |
0.2 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.1 |
0.1 |
GO:0031077 |
post-embryonic camera-type eye development(GO:0031077) |
| 0.1 |
0.3 |
GO:0055010 |
ventricular cardiac muscle tissue morphogenesis(GO:0055010) |
| 0.1 |
1.4 |
GO:2000045 |
regulation of G1/S transition of mitotic cell cycle(GO:2000045) |
| 0.1 |
0.1 |
GO:0048069 |
eye pigmentation(GO:0048069) |
| 0.1 |
0.2 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.1 |
0.8 |
GO:0060706 |
cell differentiation involved in embryonic placenta development(GO:0060706) |
| 0.1 |
0.5 |
GO:0009992 |
cellular water homeostasis(GO:0009992) |
| 0.1 |
0.1 |
GO:0048742 |
regulation of skeletal muscle fiber development(GO:0048742) |
| 0.1 |
12.8 |
GO:0006412 |
translation(GO:0006412) |
| 0.1 |
0.2 |
GO:0034047 |
regulation of protein phosphatase type 2A activity(GO:0034047) |
| 0.1 |
0.5 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.1 |
0.2 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 0.1 |
0.2 |
GO:0018002 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.1 |
0.2 |
GO:0010528 |
regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.1 |
0.2 |
GO:0048311 |
mitochondrion distribution(GO:0048311) |
| 0.1 |
0.1 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.1 |
0.1 |
GO:0033299 |
secretion of lysosomal enzymes(GO:0033299) |
| 0.1 |
0.4 |
GO:0045954 |
positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
| 0.1 |
0.1 |
GO:0060457 |
negative regulation of digestive system process(GO:0060457) |
| 0.1 |
0.2 |
GO:0003417 |
growth plate cartilage development(GO:0003417) |
| 0.1 |
0.1 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 0.1 |
0.5 |
GO:0006353 |
DNA-templated transcription, termination(GO:0006353) |
| 0.1 |
0.1 |
GO:0033601 |
positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.1 |
0.2 |
GO:2000049 |
positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.1 |
0.3 |
GO:0016255 |
attachment of GPI anchor to protein(GO:0016255) |
| 0.1 |
0.3 |
GO:0003382 |
epithelial cell morphogenesis(GO:0003382) |
| 0.1 |
0.7 |
GO:0032781 |
positive regulation of ATPase activity(GO:0032781) |
| 0.0 |
0.7 |
GO:0045662 |
negative regulation of myoblast differentiation(GO:0045662) |
| 0.0 |
0.4 |
GO:0034219 |
carbohydrate transmembrane transport(GO:0034219) |
| 0.0 |
0.6 |
GO:1900087 |
positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
| 0.0 |
0.8 |
GO:0046033 |
AMP metabolic process(GO:0046033) |
| 0.0 |
0.3 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.0 |
0.1 |
GO:1902116 |
negative regulation of organelle assembly(GO:1902116) |
| 0.0 |
0.0 |
GO:0070837 |
dehydroascorbic acid transport(GO:0070837) |
| 0.0 |
0.1 |
GO:0008300 |
isoprenoid catabolic process(GO:0008300) |
| 0.0 |
0.2 |
GO:0039703 |
viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.0 |
0.1 |
GO:0001928 |
regulation of exocyst assembly(GO:0001928) |
| 0.0 |
0.2 |
GO:0032402 |
establishment of melanosome localization(GO:0032401) melanosome transport(GO:0032402) pigment granule transport(GO:0051904) establishment of pigment granule localization(GO:0051905) |
| 0.0 |
0.1 |
GO:0015732 |
prostaglandin transport(GO:0015732) |
| 0.0 |
0.4 |
GO:0070207 |
protein homotrimerization(GO:0070207) |
| 0.0 |
0.4 |
GO:0006706 |
steroid catabolic process(GO:0006706) |
| 0.0 |
0.2 |
GO:0003170 |
heart valve development(GO:0003170) |
| 0.0 |
0.3 |
GO:0036233 |
glycine import(GO:0036233) |
| 0.0 |
1.3 |
GO:0061077 |
chaperone-mediated protein folding(GO:0061077) |
| 0.0 |
0.1 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.0 |
0.7 |
GO:0000079 |
regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) regulation of cyclin-dependent protein kinase activity(GO:1904029) |
| 0.0 |
0.2 |
GO:1904152 |
regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
| 0.0 |
0.6 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.0 |
0.5 |
GO:0035329 |
hippo signaling(GO:0035329) |
| 0.0 |
0.3 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.0 |
0.3 |
GO:2001244 |
positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
| 0.0 |
0.1 |
GO:0036289 |
peptidyl-serine autophosphorylation(GO:0036289) |
| 0.0 |
0.7 |
GO:0030970 |
retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.0 |
0.2 |
GO:0006678 |
glucosylceramide metabolic process(GO:0006678) |
| 0.0 |
0.5 |
GO:0002437 |
inflammatory response to antigenic stimulus(GO:0002437) |
| 0.0 |
0.5 |
GO:0007368 |
determination of left/right symmetry(GO:0007368) |
| 0.0 |
0.3 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
| 0.0 |
0.0 |
GO:1902414 |
protein localization to cell junction(GO:1902414) |
| 0.0 |
0.3 |
GO:0006471 |
protein ADP-ribosylation(GO:0006471) |
| 0.0 |
0.1 |
GO:0060216 |
definitive hemopoiesis(GO:0060216) |
| 0.0 |
0.2 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.0 |
0.2 |
GO:0019731 |
antibacterial humoral response(GO:0019731) |
| 0.0 |
0.0 |
GO:0030050 |
vesicle transport along actin filament(GO:0030050) |
| 0.0 |
0.0 |
GO:0098528 |
skeletal muscle fiber differentiation(GO:0098528) |
| 0.0 |
0.4 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.0 |
0.1 |
GO:0090201 |
negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
| 0.0 |
0.1 |
GO:0051661 |
maintenance of centrosome location(GO:0051661) |
| 0.0 |
0.1 |
GO:1902224 |
cellular ketone body metabolic process(GO:0046950) ketone body metabolic process(GO:1902224) |
| 0.0 |
0.5 |
GO:0032958 |
inositol phosphate biosynthetic process(GO:0032958) |
| 0.0 |
0.0 |
GO:0060431 |
primary lung bud formation(GO:0060431) |
| 0.0 |
0.6 |
GO:0006378 |
mRNA polyadenylation(GO:0006378) |
| 0.0 |
0.1 |
GO:0008594 |
photoreceptor cell morphogenesis(GO:0008594) |
| 0.0 |
0.2 |
GO:0097503 |
sialylation(GO:0097503) |
| 0.0 |
0.1 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.0 |
0.3 |
GO:0030901 |
midbrain development(GO:0030901) |
| 0.0 |
0.1 |
GO:0044861 |
protein transport into plasma membrane raft(GO:0044861) |
| 0.0 |
0.1 |
GO:0006116 |
NADH oxidation(GO:0006116) |
| 0.0 |
0.1 |
GO:0052803 |
imidazole-containing compound metabolic process(GO:0052803) |
| 0.0 |
0.0 |
GO:0019730 |
antimicrobial humoral response(GO:0019730) |
| 0.0 |
0.1 |
GO:0086018 |
SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
| 0.0 |
0.1 |
GO:0045056 |
transcytosis(GO:0045056) |
| 0.0 |
0.1 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 0.0 |
0.0 |
GO:0060971 |
embryonic heart tube left/right pattern formation(GO:0060971) |
| 0.0 |
0.2 |
GO:0008631 |
intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
| 0.0 |
0.1 |
GO:0042538 |
hyperosmotic salinity response(GO:0042538) |
| 0.0 |
0.1 |
GO:0042462 |
eye photoreceptor cell development(GO:0042462) |
| 0.0 |
0.1 |
GO:0021780 |
oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 0.0 |
0.1 |
GO:0048211 |
Golgi vesicle docking(GO:0048211) |
| 0.0 |
1.0 |
GO:0044264 |
cellular polysaccharide metabolic process(GO:0044264) |
| 0.0 |
0.1 |
GO:0045742 |
positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
| 0.0 |
0.1 |
GO:0015858 |
nucleoside transport(GO:0015858) |
| 0.0 |
0.0 |
GO:0071347 |
cellular response to interleukin-1(GO:0071347) |
| 0.0 |
0.1 |
GO:0002553 |
histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 0.0 |
0.2 |
GO:0048706 |
embryonic skeletal system development(GO:0048706) |
| 0.0 |
0.2 |
GO:0050884 |
neuromuscular process controlling posture(GO:0050884) |
| 0.0 |
0.1 |
GO:0043330 |
response to exogenous dsRNA(GO:0043330) |
| 0.0 |
0.0 |
GO:0045599 |
negative regulation of fat cell differentiation(GO:0045599) |
| 0.0 |
0.1 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.0 |
0.4 |
GO:0001824 |
blastocyst development(GO:0001824) |
| 0.0 |
0.1 |
GO:0051180 |
vitamin transport(GO:0051180) |
| 0.0 |
0.5 |
GO:0070936 |
protein K48-linked ubiquitination(GO:0070936) |
| 0.0 |
0.7 |
GO:0021915 |
neural tube development(GO:0021915) |
| 0.0 |
0.3 |
GO:0044380 |
protein localization to cytoskeleton(GO:0044380) |
| 0.0 |
0.1 |
GO:0006884 |
cell volume homeostasis(GO:0006884) |
| 0.0 |
0.4 |
GO:1901799 |
negative regulation of proteasomal protein catabolic process(GO:1901799) |
| 0.0 |
0.0 |
GO:0009451 |
RNA modification(GO:0009451) |
| 0.0 |
0.1 |
GO:0042755 |
eating behavior(GO:0042755) |
| 0.0 |
0.0 |
GO:0035973 |
aggrephagy(GO:0035973) |
| 0.0 |
0.1 |
GO:0031293 |
membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.0 |
0.2 |
GO:0045143 |
homologous chromosome segregation(GO:0045143) |
| 0.0 |
0.0 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.0 |
0.0 |
GO:0031065 |
positive regulation of histone deacetylation(GO:0031065) |
| 0.0 |
0.2 |
GO:0010761 |
fibroblast migration(GO:0010761) |
| 0.0 |
0.1 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.0 |
0.1 |
GO:0046685 |
response to arsenic-containing substance(GO:0046685) |
| 0.0 |
0.1 |
GO:0071218 |
cellular response to misfolded protein(GO:0071218) |
| 0.0 |
0.1 |
GO:0042559 |
pteridine-containing compound biosynthetic process(GO:0042559) |
| 0.0 |
0.0 |
GO:0072015 |
glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
| 0.0 |
0.1 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.0 |
0.1 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.0 |
0.1 |
GO:0006501 |
C-terminal protein lipidation(GO:0006501) |
| 0.0 |
0.2 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.0 |
0.1 |
GO:0044783 |
G1 DNA damage checkpoint(GO:0044783) |
| 0.0 |
0.1 |
GO:1902259 |
regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.0 |
0.1 |
GO:0003085 |
negative regulation of systemic arterial blood pressure(GO:0003085) |
| 0.0 |
0.1 |
GO:0051220 |
cytoplasmic sequestering of protein(GO:0051220) |
| 0.0 |
0.0 |
GO:0002578 |
negative regulation of antigen processing and presentation(GO:0002578) |
| 0.0 |
0.1 |
GO:0008272 |
sulfate transport(GO:0008272) |
| 0.0 |
0.0 |
GO:0071816 |
protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.0 |
0.2 |
GO:0042493 |
response to drug(GO:0042493) |
| 0.0 |
0.1 |
GO:0070534 |
protein K63-linked ubiquitination(GO:0070534) |
| 0.0 |
0.0 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.0 |
0.0 |
GO:1902109 |
negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 0.0 |
0.1 |
GO:0033572 |
transferrin transport(GO:0033572) |
